{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:13:53Z","timestamp":1753892033990,"version":"3.41.2"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"publisher","award":["K01TW011470"],"award-info":[{"award-number":["K01TW011470"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U54CA25464, U54CA190152"],"award-info":[{"award-number":["U54CA25464, U54CA190152"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Multicentric Castleman disease (MCD) is a lymphoproliferative disorder characterized by systemic inflammation, lymphadenopathy, and cytopenias. MCD caused by Kaposi sarcoma herpesvirus (MCD-KSHV) frequently arises in the context of HIV. It can be associated with immune reconstitution inflammatory syndrome (IRIS), but MCD-IRIS is rarely reported in sub-Saharan Africa (SSA) where HIV and KSHV infection are common.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case description<\/jats:title><jats:p>A 36-year-old woman in Malawi with HIV on antiretroviral therapy (ART) for nine years presented with fatigue, weight loss, and lymphadenopathy. Lymph node biopsy was consistent with HIV lymphadenitis without evident KSHV-MCD and HIV RNA was 4,244 copies\/mL. She switched to second-line ART and returned four months later with worsening lymphadenopathy, fever, night sweats, weight loss, and anemia. A repeat lymph node biopsy demonstrated unequivocal KSHV-MCD features not present on the original biopsy. Her repeat HIV viral load was undetectable and she received chemotherapy with subsequent remission on continued ART for 24 months.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>This is among the first reported cases of MCD-IRIS from SSA, which has implications for a region where HIV and KSHV are highly prevalent. MCD-IRIS may contribute to early mortality after ART initiation in SSA, and increased awareness alongside improved diagnostic and treatment capacity are needed.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2022.969135","type":"journal-article","created":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T06:08:07Z","timestamp":1670825287000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Case report: Multicentric Castleman disease as a manifestation of immune reconstitution inflammatory syndrome in Malawi"],"prefix":"10.3389","volume":"12","author":[{"given":"Matthew S.","family":"Painschab","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marriam","family":"Mponda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamiwe","family":"Tomoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Coxcilly","family":"Kampani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fred","family":"Chimzimu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuri","family":"Fedoriw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satish","family":"Gopal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.hoc.2017.09.002","article-title":"Castleman disease pathogenesis","volume":"32","author":"Fajgenbaum","year":"2018","journal-title":"Hematol Oncol Clin North Am"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(195607\/08)9:4<822::AID-CNCR2820090430>3.0.CO;2-4","article-title":"Localized mediastinal lymph-node hyperplasia resembling thymoma","volume":"9","author":"Castleman","year":"1956","journal-title":"Cancer"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-11-852442","article-title":"Kaposi sarcoma-associated herpesvirus\/human herpesvirus 8-associated lymphoproliferative disorder","volume":"133","author":"Oksenhendler","year":"2019","journal-title":"Blood"},{"key":"B4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41572-019-0060-9","article-title":"Kaposi sarcoma","volume":"5","author":"Cesarman","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/v10090458","article-title":"HHV-8 seroprevalence and genotype distribution in Africa, 1998(-)2017: A systematic review","volume":"10","author":"Etta","year":"2018","journal-title":"Viruses"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.204479","article-title":"A prospective description of HIV-associated multicentric castleman disease in Malawi","author":"Tomoka","year":"2018","journal-title":"Haematologica"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/aqw118","article-title":"Accurate real-time diagnosis of lymphoproliferative disorders in Malawi through clinicopathologic teleconferences: A model for pathology services in Sub-Saharan Africa","volume":"146","author":"Montgomery","year":"2016","journal-title":"Am J Clin Pathol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"20122","DOI":"10.7448\/IAS.18.1.20122","article-title":"Characteristics and survival for HIV-associated multicentric castleman disease in Malawi","volume":"18","author":"Gopal","year":"2015","journal-title":"J Int AIDS Soc"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(10)70026-8","article-title":"Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: A systematic review and meta-analysis","volume":"2010","author":"Muller","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3282f4a607","article-title":"Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in south Africa: a prospective study","volume":"22","author":"Murdoch","year":"2008","journal-title":"AIDS"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328360a5a1","article-title":"Immune reconstitution inflammatory syndrome associated with kaposi sarcoma: higher incidence and mortality in Africa than in the UK","volume":"27","author":"Letang","year":"2013","journal-title":"AIDS"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.14.597","article-title":"Immune reconstitution inflammatory syndrome associated with kaposi's sarcoma","volume":"23","author":"Bower","year":"2005","journal-title":"J Clin Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.34.1909","article-title":"Clinical features and outcome in HIV-associated multicentric castleman's disease","volume":"29","author":"Bower","year":"2011","journal-title":"J Clin Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdn697","article-title":"The role of immune suppression and HHV-8 in the increasing incidence of HIV-associated multicentric castleman's disease","volume":"20","author":"Powles","year":"2009","journal-title":"Ann Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.12890\/2015_000251","article-title":"Lymphadenopathy after initiating HAART in an HIV-positive patient with kaposi sarcoma: a case of multicentric castleman disease","author":"Micallef","year":"2015","journal-title":"Eur J Case Rep Internal Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ijid.2016.05.005","article-title":"Immune reconstitution inflammatory syndrome, human herpesvirus 8 viremia, and HIV-associated multicentric castleman disease","volume":"48","author":"Siegel","year":"2016","journal-title":"Int J Infect Dis"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199906173402415","article-title":"An unusual cluster of cases of castleman\u2019s disease during highly active antiretroviral therapy for AIDS","volume":"340","author":"Zietz","year":"1999","journal-title":"N Engl J Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"460701","DOI":"10.1155\/2013\/460701","article-title":"A rare case of immune reconstitution inflammatory syndrome development in an immunocompromised patient with progressive multifocal leukoencephalopathy and multicentric castleman's disease","volume":"2013","author":"Kurukumbi","year":"2013","journal-title":"Case Rep Neurol Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.5772\/61709","article-title":"Multicentric castleman\u2019s disease","author":"Patel","year":"2015","journal-title":"Immunopathol Immunomodulation"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0020010","article-title":"Early mortality and AIDS progression despite high initial antiretroviral therapy adherence and virologic suppression in Botswana","volume":"6","author":"Steele","year":"2011","journal-title":"PloS One"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ996","article-title":"Clinical features and outcomes of patients with symptomatic kaposi sarcoma herpesvirus (KSHV)-associated inflammation: Prospective characterization of KSHV inflammatory cytokine syndrome (KICS)","volume":"62","author":"Polizzotto","year":"2016","journal-title":"Clin Infect Dis"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16575","article-title":"Clinical presentation and diagnosis of adult patients with non-Hodgkin lymphoma in Sub-Saharan Africa","volume":"190","author":"Mezger","year":"2020","journal-title":"Br J Haematol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-016-0959-z","article-title":"PD-1\/PD-L1 blockade in cancer treatment: perspectives and issues","volume":"21","author":"Hamanishi","year":"2016","journal-title":"Int J Clin Oncol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.01.003","article-title":"Improving access to immunotherapy in low- and middle-income countries","volume":"33","author":"Patel","year":"2022","journal-title":"Ann Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.2244","article-title":"Assessment of the safety of pembrolizumab in patients with HIV and advanced cancer-a phase 1 study","author":"Uldrick","year":"2019","journal-title":"JAMA Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.969135\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T06:08:10Z","timestamp":1670825290000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.969135\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,12]]},"references-count":25,"alternative-id":["10.3389\/fonc.2022.969135"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.969135","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2022,12,12]]},"article-number":"969135"}}